|

Belimumab Clinical Trials

5 actively recruiting trials across 2 locations

Also known as: Any other treatment, Benlysta

Other3 trials

Belimumab After Rituximab in Resistant Primary Juvenile SS
Phase 4
Belimumab in SLE Synovial Inflammation and Lymph Nodes
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Phase 2

Scottsdale, Arizona1 trial

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants

GSK Investigational Site

Phase 1

Manhasset, New York1 trial

Trial of Belimumab in Early Lupus

Feinstein Institute

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.